Early T helper cell programming of gene expression in human

Seminars in Immunology

Volumn 25, Issue 4, 2013, Pages 282-290

  Tuomela, Soile ^a   Lahesmaa, Riitta ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Epigenetics; Genome wide; High throughput; Human; T helper cell; Transcription

Indexed keywords

UNTRANSLATED RNA;

CELL MATURATION; EPIGENETICS; GENE EXPRESSION; HELPER CELL; HIGH THROUGHPUT SCREENING; HUMAN; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; NUCLEAR REPROGRAMMING; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; RNA PROCESSING; TFH CELL; TH1 CELL; TH17 CELL; TH2 CELL; TH22 CELL; TH9 CELL; TRANSCRIPTION REGULATION;

CHIA-PET; CHIP; CHIP-SEQ; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN IMMUNOPRECIPITATION COUPLED TO HIGH-THROUGHPUT SEQUENCING; CHROMATIN INTERACTION ANALYSIS BY PAIRED-END TAG SEQUENCING; EPIGENETICS; FOLLICULAR T HELPER CELL; GENOME-WIDE; HIGH-THROUGHPUT; HIGH-THROUGHPUT RNA SEQUENCING; HUMAN; INDUCIBLE T REGULATORY CELL, ADAPTIVE T REGULATORY; ITREG; LINCRNA; LNCRNA; LONG INTERGENIC NON-CODING RNA; LONG NON-CODING RNA; MICRORNA; MIRNA; RNA INTERFERENCE; RNA-SEQ; RNAI; SHORT INTERFERING RNA; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION; SINGLE NUCLEOTIDE POLYMORPHISM; SIRNA; SNP; STAT; T CELL RECEPTOR; T HELPER CELL; TCR; TFH; TH; TRANSCRIPTION; UNTRANSLATED REGION OF MRNA; UTR;

CELL DIFFERENTIATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TRANSCRIPTION, GENETIC;

EID: 84888861827     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.10.013     Document Type: Review

References (128)

1. Rice J. Animal models: not close enough. Nature 2012, 484:S9.
2. van der Worp H.B., Howells D.W., Sena E.S., Porritt M.J., Rewell S., O'Collins V., et al. Can animal models of disease reliably inform human studies?. PLoS Med 2010, 7:e1000245.
3. Karp C.L. Unstressing intemperate models: how cold stress undermines mouse modeling. J Exp Med 2012, 209:1069-1074.
4. Chen Z., Cheng K., Walton Z., Wang Y., Ebi H., Shimamura T., et al. A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature 2012, 483:613-617.
5. Mestas J., Hughes C.C. Of mice and not men: differences between mouse and human immunology. J Immunol 2004, 172:2731-2738.
6. den Braber I., Mugwagwa T., Vrisekoop N., Westera L., Mogling R., de Boer A.B., et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 2012, 36:288-297.
7. Seok J., Warren H.S., Cuenca A.G., Mindrinos M.N., Baker H.V., Xu W., et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013, 110:3507-3512.
8. Liew F.Y. T(H)1 and T(H)2 cells: a historical perspective. Nat Rev Immunol 2002, 2:55-60.
9. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173.
10. Filipe-Santos O., Bustamante J., Chapgier A., Vogt G., de Beaucoudrey L., Feinberg J., et al. Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006, 18:347-361.
11. Pulendran B., Artis D. New paradigms in type 2 immunity. Science 2012, 337:431-435.
12. Hirahara K., Poholek A., Vahedi G., Laurence A., Kanno Y., Milner J.D., et al. Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease. J Allergy Clin Immunol 2013, 131:1276-1287.
13. Bilate A.M., Lafaille J.J. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu Rev Immunol 2012, 30:733-758.
14. Lehtimäki S., Lahesmaa R. Regulatory T cells control immune responses through their non-redundant tissue specific features. Front Immunol 2013, 4:294.
15. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest 2003, 112:1437-1443.
16. Tran D.Q., Ramsey H., Shevach E.M. Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T-cell receptor stimulation is transforming growth factor-β dependent but does not confer a regulatory phenotype. Blood 2007, 110:2983-2990.
17. + regulatory T cells. Nat Immunol 2013, 14:162-171.
18. Lu L., Zhou X., Wang J., Zheng S.G., Horwitz D.A. Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid. PLoS ONE 2010, 5:e15150.
19. Schaerli P., Willimann K., Lang A.B., Lipp M., Loetscher P., Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000, 192:1553-1562.
20. Breitfeld D., Ohl L., Kremmer E., Ellwart J., Sallusto F., Lipp M., et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000, 192:1545-1552.
21. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011, 29:621-663.
22. Wong M.T., Ye J.J., Alonso M.N., Landrigan A., Cheung R.K., Engleman E., et al. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol 2010, 88:624-631.
23. Staudt V., Bothur E., Klein M., Lingnau K., Reuter S., Grebe N., et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010, 33:192-202.
24. Kaplan M.H. Th9 cells: differentiation and disease. Immunol Rev 2013, 252:104-115.
25. Eyerich S., Eyerich K., Pennino D., Carbone T., Nasorri F., Pallotta S., et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009, 119:3573-3585.
26. Trifari S., Kaplan C.D., Tran E.H., Crellin N.K., Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009, 10:864-871.
27. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009, 10:857-863.
28. Basu R., O'Quinn D.B., Silberger D.J., Schoeb T.R., Fouser L., Ouyang W., et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012, 37:1061-1075.
29. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
30. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature 2010, 467:967-971.
31. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8:950-957.
32. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007, 8:639-646.
33. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007, 204:1849-1861.
34. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu Rev Immunol 2009, 27:485-517.
35. Rautajoki K.J., Marttila E.M., Nyman T.A., Lahesmaa R. Interleukin-4 inhibits caspase-3 by regulating several proteins in the fas pathway during initial stages of human T helper 2 cell differentiation. Mol Cell Proteomics 2007, 6:238-251.
36. Hannet I., Erkeller-Yuksel F., Lydyard P., Deneys V., DeBruyere M. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 1992, 13(215):218.
37. Ramming A., Druzd D., Leipe J., Schulze-Koops H., Skapenko A. Maturation-related histone modifications in the PU.1 promoter regulate Th9-cell development. Blood 2012, 119:4665-4674.
38. Chen L., Cohen A.C., Lewis D.B. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells. Biol Blood Marrow Transplant 2006, 12:160-171.
39. Zaghouani H., Hoeman C.M., Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 2009, 30:585-591.
40. Doganci A., Birkholz J., Gehring S., Puhl A.G., Zepp F., Meyer C.U. In the presence of IL-21 human cord blood T cells differentiate to IL-10-producing Th1 but not Th17 or Th2 cells. Int Immunol 2013, 25:157-169.
41. Elo L.L., Järvenpää H., Tuomela S., Raghav S., Ahlfors H., Laurila K., et al. Genome-wide profiling of interleukin-4 and STAT6 transcription factor regulation of human Th2 cell programming. Immunity 2010, 32:852-862.
42. Äijö T., Edelman S.M., Lönnberg T., Larjo A., Kallionpää H., Tuomela S., et al. An integrative computational systems biology approach identifies differentially regulated dynamic transcriptome signatures which drive the initiation of human T helper cell differentiation. BMC Genomics 2012, 13:572.
43. Lund R., Aittokallio T., Nevalainen O., Lahesmaa R. Identification of novel genes regulated by IL-12, IL-4, or TGF-β during the early polarization of CD4+ lymphocytes. J Immunol 2003, 171:5328-5336.
44. Tuomela S., Salo V., Tripathi S.K., Chen Z., Laurila K., Gupta B., et al. Identification of early gene expression changes during human Th17 cell differentiation. Blood 2012, 119:e151-e160.
45. Chtanova T., Tangye S.G., Newton R., Frank N., Hodge M.R., Rolph M.S., et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 2004, 173:68-78.
46. Prots I., Skapenko A., Lipsky P.E., Schulze-Koops H. Analysis of the transcriptional program of developing induced regulatory T cells. PLoS ONE 2011, 6:e16913.
47. van den Ham H.J., de Waal L., Andeweg A.C., de Boer R.J. Identification of helper T cell master regulator candidates using the polar score method. J Immunol Methods 2010, 361:98-109.
48. Lund R., Ahlfors H., Kainonen E., Lahesmaa A.M., Dixon C., Lahesmaa R. Identification of genes involved in the initiation of human Th1 or Th2 cell commitment. Eur J Immunol 2005, 35:3307-3319.
49. Lund R.J., Löytömäki M., Naumanen T., Dixon C., Chen Z., Ahlfors H., et al. Genome-wide identification of novel genes involved in early Th1 and Th2 cell differentiation. J Immunol 2007, 178:3648-3660.
50. Elo L.L., Lahti L., Skottman H., Kyläniemi M., Lahesmaa R., Aittokallio T. Integrating probe-level expression changes across generations of Affymetrix arrays. Nucleic Acids Res 2005, 33:e193.
51. Elo L.L., Järvenpää H., Oresic M., Lahesmaa R., Aittokallio T. Systematic construction of gene coexpression networks with applications to human T helper cell differentiation process. Bioinformatics 2007, 23:2096-2103.
52. Crotty S. The 1-1-1 fallacy. Immunol Rev 2012, 247:133-142.
53. Tahvanainen J., Pykäläinen M., Kallonen T., Lähteenmäki H., Rasool O., Lahesmaa R. Enrichment of nucleofected primary human CD4+ T cells: a novel and efficient method for studying gene function and role in human primary T helper cell differentiation. J Immunol Methods 2006, 310:30-39.
54. Filén S., Ylikoski E., Tripathi S., West A., Björkman M., Nyström J., et al. Activating transcription factor 3 is a positive regulator of human IFNG gene expression. J Immunol 2010, 184:4990-4999.
55. Tahvanainen J., Kyläniemi M.K., Kanduri K., Gupta B., Lähteenmäki H., Kallonen T., et al. Proviral integration site for moloney murine leukemia virus (PIM) kinases promote human T helper 1 cell differentiation. J Biol Chem 2013, 288:3048-3058.
56. Tahvanainen J., Kallonen T., Lähteenmäki H., Heiskanen K.M., Westermarck J., Rao K.V., et al. PRELI is a mitochondrial regulator of human primary T-helper cell apoptosis, STAT6, and Th2-cell differentiation. Blood 2009, 113:1268-1277.
57. Ahlfors H., Limaye A., Elo L.L., Tuomela S., Burute M., Gottimukkala K.V., et al. SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiation. Blood 2010, 116:1443-1453.
58. Jackson A.L., Linsley P.S. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 2010, 9:57-67.
59. Yosef N., Shalek A.K., Gaublomme J.T., Jin H., Lee Y., Awasthi A., et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature 2013, 496:461-468.
60. Wei L., Vahedi G., Sun H.W., Watford W.T., Takatori H., Ramos H.L., et al. Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation. Immunity 2010, 32:840-851.
61. Evans C.M., Jenner R.G. Transcription factor interplay in T helper cell differentiation. Brief Funct Genomics 2013, August 29 [Epub ahead of print].
62. Ciofani M., Madar A., Galan C., Sellars M., Mace K., Pauli F., et al. A validated regulatory network for Th17 cell specification. Cell 2012, 151:289-303.
63. Kanhere A., Hertweck A., Bhatia U., Gokmen M.R., Perucha E., Jackson I., et al. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements. Nat Commun 2012, 3:1268.
64. Jenner R.G., Townsend M.J., Jackson I., Sun K., Bouwman R.D., Young R.A., et al. The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. Proc Natl Acad Sci U S A 2009, 106:17876-17881.
65. Ansel K.M., Lee D.U., Rao A. An epigenetic view of helper T cell differentiation. Nat Immunol 2003, 4:616-623.
66. Kanno Y., Vahedi G., Hirahara K., Singleton K., O'Shea J.J. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol 2012, 30:707-731.
67. Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. ENCODE Project Consortium.
68. Lovinsky-Desir S., Miller R.L. Epigenetics, asthma, and allergic diseases: a review of the latest advancements. Curr Allergy Asthma Rep 2012, 12:211-220.
69. Ngalamika O., Zhang Y., Yin H., Zhao M., Gershwin M.E., Lu Q. Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. J Autoimmun 2012, 39:451-465.
70. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
71. Schones D.E., Cui K., Cuddapah S., Roh T.Y., Barski A., Wang Z., et al. Dynamic regulation of nucleosome positioning in the human genome. Cell 2008, 132:887-898.
72. Wang Z., Zang C., Rosenfeld J.A., Schones D.E., Barski A., Cuddapah S., et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008, 40:897-903.
73. Boyle A.P., Davis S., Shulha H.P., Meltzer P., Margulies E.H., Weng Z., et al. High-resolution mapping and characterization of open chromatin across the genome. Cell 2008, 132:311-322.
74. Schmidl C., Klug M., Boeld T.J., Andreesen R., Hoffmann P., Edinger M., et al. Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res 2009, 19:1165-1174.
75. Hawkins R.D., Larjo A., Tripathi S.K., Wagner U., Luu Y., Lönnberg T., et al. Global chromatin state analysis reveals lineage-specific enhancers during the initiation of human T helper 1 and T helper 2 cell polarization. Immunity 2013, 38:1271-1284.
76. Wei G., Wei L., Zhu J., Zang C., Hu-Li J., Yao Z., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30:155-167.
77. Lu K.T., Kanno Y., Cannons J.L., Handon R., Bible P., Elkahloun A.G., et al. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity 2011, 35:622-632.
78. Durant L., Watford W.T., Ramos H.L., Laurence A., Vahedi G., Wei L., et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010, 32:605-615.
79. Vahedi G., Takahashi H., Nakayamada S., Sun H.W., Sartorelli V., Kanno Y., et al. STATs shape the active enhancer landscape of T cell populations. Cell 2012, 151:981-993.
80. Wei G., Abraham B.J., Yagi R., Jothi R., Cui K., Sharma S., et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 2011, 35:299-311.
81. Samstein R.M., Arvey A., Josefowicz S.Z., Peng X., Reynolds A., Sandstrom R., et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 2012, 151:153-166.
82. Vahedi G., Poholek A.C., Hand T.W., Laurence A., Kanno Y., O'Shea J.J., et al. Helper T-cell identity and evolution of differential transcriptomes and epigenomes. Immunol Rev 2013, 252:24-40.
83. Ong C.T., Corces V.G. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet 2011, 12:283-293.
84. Nakayamada S., Kanno Y., Takahashi H., Jankovic D., Lu K.T., Johnson T.A., et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 2011, 35:919-931.
85. Zhu J., Jankovic D., Oler A.J., Wei G., Sharma S., Hu G., et al. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 2012, 37:660-673.
86. Cai S., Lee C.C., Kohwi-Shigematsu T. SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 2006, 38:1278-1288.
87. Spilianakis C.G., Flavell R.A. Long-range intrachromosomal interactions in the T helper type 2 cytokine locus. Nat Immunol 2004, 5:1017-1027.
88. Spilianakis C.G., Lalioti M.D., Town T., Lee G.R., Flavell R.A. Interchromosomal associations between alternatively expressed loci. Nature 2005, 435:637-645.
89. Beyer M., Thabet Y., Muller R.U., Sadlon T., Classen S., Lahl K., et al. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat Immunol 2011, 12:898-907.
90. Bandukwala H.S., Wu Y., Feuerer M., Chen Y., Barboza B., Ghosh S., et al. Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. Immunity 2011, 34:479-491.
91. Chen Y., Bates D.L., Dey R., Chen P.H., Machado A.C., Laird-Offringa I.A., et al. DNA binding by GATA transcription factor suggests mechanisms of DNA looping and long-range gene regulation. Cell Rep 2012, 2:1197-1206.
92. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., et al. Landscape of transcription in human cells. Nature 2012, 489:101-108.
93. Ip J.Y., Tong A., Pan Q., Topp J.D., Blencowe B.J., Lynch K.W. Global analysis of alternative splicing during T-cell activation. RNA 2007, 13:563-572.
94. Dang E.V., Barbi J., Yang H.Y., Jinasena D., Yu H., Zheng Y., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
95. Skapenko A., Leipe J., Niesner U., Devriendt K., Beetz R., Radbruch A., et al. GATA-3 in human T cell helper type 2 development. J Exp Med 2004, 199:423-428.
96. Kryczek I., Zhao E., Liu Y., Wang Y., Vatan L., Szeliga W., et al. Human TH17 cells are long-lived effector memory cells. Sci Transl Med 2011, 3:104ra100.
97. Oberdoerffer S., Moita L.F., Neems D., Freitas R.P., Hacohen N., Rao A. Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Science 2008, 321:686-691.
98. Wu Z., Jia X., de la Cruz L., Su X.C., Marzolf B., Troisch P., et al. Memory T cell RNA rearrangement programmed by heterogeneous nuclear ribonucleoprotein hnRNPLL. Immunity 2008, 29:863-875.
99. Ichiyama K., Yoshida H., Wakabayashi Y., Chinen T., Saeki K., Nakaya M., et al. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. J Biol Chem 2008, 283:17003-17008.
100. Du J., Huang C., Zhou B., Bluestone J.A., Ziegler S.F. Isoform-specific inhibition of ROR α-mediated transcriptional activation by human FOXP3. J Immunol 2008, 180:4785-4792.
101. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011, 12:861-874.
102. Baumjohann D., Ansel K.M. MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat Rev Immunol 2013, 13:666-678.
103. Muljo S.A., Ansel K.M., Kanellopoulou C., Livingston D.M., Rao A., Rajewsky K., et al. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005, 202:261-269.
104. Cobb B.S., Hertweck A., Smith J., O'Connor E., Graf D., Cook T., et al. A role for Dicer in immune regulation. J Exp Med 2006, 203:2519-2527.
105. Liston A., Lu L.F., O'Carroll D., Tarakhovsky A., Rudensky A.Y. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 2008, 205:1993-2004.
106. Chong M.M., Rasmussen J.P., Rudensky A.Y., Littman D.R. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 2008, 205:2005-2017.
107. Zhou X., Jeker L.T., Fife B.T., Zhu S., Anderson M.S., McManus M.T., et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 2008, 205:1983-1991.
108. Rossi R.L., Rossetti G., Wenandy L., Curti S., Ripamonti A., Bonnal R.J., et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 2011, 12:796-803.
109. Sandberg R., Neilson J.R., Sarma A., Sharp P.A., Burge C.B. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 2008, 320:1643-1647.
110. Bronevetsky Y., Villarino A.V., Eisley C.J., Barbeau R., Barczak A.J., Heinz G.A., et al. T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire. J Exp Med 2013, 210:417-432.
111. Kuchen S., Resch W., Yamane A., Kuo N., Li Z., Chakraborty T., et al. Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 2010, 32:828-839.
112. Hu G., Tang Q., Sharma S., Yu F., Escobar T.M., Muljo S.A., et al. Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation. Nat Immunol 2013, 14:1190-1198.
113. Pagani M., Rossetti G., Panzeri I., de Candia P., Bonnal R.J., Rossi R.L., et al. Role of microRNAs and long-non-coding RNAs in CD4(+) T-cell differentiation. Immunol Rev 2013, 253:82-96.
114. Zhang H., Nestor C.E., Zhao S., Lentini A., Bohle B., Benson M., et al. Profiling of human CD4(+) T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1. J Allergy Clin Immunol 2013, July 16 [Epub ahead of print].
115. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012, 22:1775-1789.
116. Moran V.A., Perera R.J., Khalil A.M. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res 2012, 40:6391-6400.
117. Collier S.P., Collins P.L., Williams C.L., Boothby M.R., Aune T.M. Cutting edge: influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J Immunol 2012, 189:2084-2088.
118. Gomez J.A., Wapinski O.L., Yang Y.W., Bureau J.F., Gopinath S., Monack D.M., et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus. Cell 2013, 152:743-754.
119. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., et al. An oestrogen-receptor-α-bound human chromatin interactome. Nature 2009, 462:58-64.
120. Helwak A., Kudla G., Dudnakova T., Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013, 153:654-665.
121. König J., Zarnack K., Luscombe N.M., Ule J. Protein-RNA interactions: new genomic technologies and perspectives. Nat Rev Genet 2012, 13:77-83.
122. Lönnberg T., Chen Z., Lahesmaa R. From a gene-centric to whole-proteome view of differentiation of T helper cell subsets. Brief Funct Genomics 2013, 7. [Epub ahead of print].
123. Moulder R., Lönnberg T., Elo L.L., Filén J.J., Rainio E., Corthals G., et al. Quantitative proteomics analysis of the nuclear fraction of human CD4+ cells in the early phases of IL-4-induced Th2 differentiation. Mol Cell Proteomics 2010, 9:1937-1953.
124. Lönnberg T., Yetukuri L., Seppänen-Laakso T., Lahesmaa R., Oresic M. T-cell activation induces selective changes of cellular lipidome. Front Biosci (Elite Ed) 2013, 5:558-573.
125. Liao W., Lin J.X., Wang L., Li P., Leonard W.J. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol 2011, 12:551-559.
126. Deaton A.M., Webb S., Kerr A.R., Illingworth R.S., Guy J., Andrews R., et al. Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res 2011, 21:1074-1086.
127. Liao W., Schones D.E., Oh J., Cui Y., Cui K., Roh T.Y., et al. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor α-chain expression. Nat Immunol 2008, 9:1288-1296.
128. Yang X.P., Ghoreschi K., Steward-Tharp S.M., Rodriguez-Canales J., Zhu J., Grainger J.R., et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat Immunol 2011, 12:247-254.